Palliative low dose fortnightly methotrexate in oral cancers: Experience at a rural cancer centre from India

CONTEXT: Palliative fortnightly chemotherapy in oral cancers. AIMS: We present our experience with a regimen employing fortnightly (once in 2 weeks) injectable methotrexate (MTX) (40 mg/m(2) ) in a predominantly elderly cohort of patients with carcinoma of oral cavity and oropharynx. SETTINGS AND DE...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Santam, Geetha, M., Sujith, K. M., Biji, M. S., Sateeshan, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
MINI SYMPOSIUM: HEAD AND NECK CANCER: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134608/
https://www.ncbi.nlm.nih.gov/pubmed/25136524
http://dx.doi.org/10.4103/2278-330X.136798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134608/
https://www.ncbi.nlm.nih.gov/pubmed/25136524
http://dx.doi.org/10.4103/2278-330X.136798

Ejemplares similares